drugset / Trial / NCT00317512

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

NCT00317512

Phase 2 Completed 45 enrolled Biopure Corporation
RandomizedFactorialTriple-blindTreatment

Summary

The purpose of this study is to assess the safety and feasibility of a novel oxygen carrying solution, HBOC-201, in the setting of PCI for Acute Coronary Syndromes from randomization til hospital discharge.

Timeline

Start
2003-12
Primary completion
2005-04
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HBOC-201 Protein / enzyme biologic 15 g Intravenous
Subject HBOC-201 Protein / enzyme biologic 30 g Intravenous
Comparator hydroxyethyl starch Other / unclassified